Difference between revisions of "Vavelta"
Jump to navigation
Jump to search
m |
m |
||
| Line 32: | Line 32: | ||
| first=Leah | | first=Leah | ||
| publisher=Daily Mail | | publisher=Daily Mail | ||
| − | | | + | | website=Mail Online |
| date=2008-11-19 | | date=2008-11-19 | ||
| title=Would you undergo anti-ageing treatment using cells from circumcised newborn babies? | | title=Would you undergo anti-ageing treatment using cells from circumcised newborn babies? | ||
Revision as of 18:39, 20 September 2019
Vavelta is a skin repair and rejuvenation product manufactured by Intercytex. It has been designed to improve the structure, function and appearance of skin damaged by scarring or the aging process. The company claims that it is being developed primarily for medical applications, but it also being used in aesthetic applications.[1][2][3]
According to the UK Daily Mail, Vavelta is derived from baby foreskins donated by mothers at a hospital in the U.S. after routine circumcision.[4]
References
- ↑
Vavelta
, Intercytex: GMP. Retrieved 7 May 2011. - ↑
A Cut above the Rest?: Wrinkle Treatment Uses Babies' Foreskins
. Retrieved 18 January 2012. - ↑
Babies’ foreskin dubbed as new anti-aging treatment
. Retrieved 16 January 2012. - ↑ Hardy, Leah (19 November 2008).
Would you undergo anti-ageing treatment using cells from circumcised newborn babies?
, Mail Online, Daily Mail. Retrieved 7 May 2011.
Quote:These are derived from baby foreskins donated by moters at a hospital in the U.S. after routine circumcision.
